# Goldman Sachs Group Inc: financial statements, quarterly

GS · NYSE · CIK 886982 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gs.md) · [Financials](/companies/gs/financials.md) · [Filings](/companies/gs/filings.md) · [Insiders](/companies/gs/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/gs/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [11.8](/filings/0000886982-24-000025.md) | [11.3 d](/filings/0000886982-26-000091.md) | [14.2](/filings/0000886982-25-000009.md) | [12.7](/filings/0000886982-25-000022.md) | [12.7](/filings/0000886982-25-001411.md) | [13.9 d](/filings/0000886982-26-000091.md) | [15.1](/filings/0000886982-26-000118.md) | [14.6](/filings/0000886982-26-000297.md) | [15.2](/filings/0000886982-25-001411.md) | [13.5 d](/filings/0000886982-26-000091.md) | [17.2](/filings/0000886982-26-000118.md) | [20.3](/filings/0000886982-26-000297.md) |
| Interest expense | $bn | [16.7](/filings/0000886982-24-000025.md) | [17.1 d](/filings/0000886982-26-000091.md) | [18.2](/filings/0000886982-25-000009.md) | [18.5](/filings/0000886982-25-000022.md) | [19.1](/filings/0000886982-25-001411.md) | [17.6 d](/filings/0000886982-26-000091.md) | [16.5](/filings/0000886982-25-000009.md) | [16.7](/filings/0000886982-25-000022.md) | [17.0](/filings/0000886982-25-001411.md) | [16.7 d](/filings/0000886982-26-000091.md) | not reported | not reported |
| Income tax | $bn | [0.7](/filings/0000886982-24-000025.md) | [0.2 d](/filings/0000886982-26-000091.md) | [1.1](/filings/0000886982-25-000009.md) | [0.9](/filings/0000886982-25-000022.md) | [1.0](/filings/0000886982-25-001411.md) | [1.1 d](/filings/0000886982-26-000091.md) | [0.9](/filings/0000886982-26-000118.md) | [1.2](/filings/0000886982-26-000297.md) | [1.3](/filings/0000886982-25-001411.md) | [1.2 d](/filings/0000886982-26-000091.md) | [0.9](/filings/0000886982-26-000118.md) | [1.9](/filings/0000886982-26-000297.md) |
| Net income | $bn | [2.1](/filings/0000886982-24-000025.md) | [2.0 d](/filings/0000886982-26-000091.md) | [4.1](/filings/0000886982-25-000009.md) | [3.0](/filings/0000886982-25-000022.md) | [3.0](/filings/0000886982-25-001411.md) | [4.1 d](/filings/0000886982-26-000091.md) | [4.7](/filings/0000886982-26-000118.md) | [3.7](/filings/0000886982-26-000297.md) | [4.1](/filings/0000886982-25-001411.md) | [4.6 d](/filings/0000886982-26-000091.md) | [5.6](/filings/0000886982-26-000118.md) | [6.6](/filings/0000886982-26-000297.md) |
| Diluted EPS | $ per share | [5.47](/filings/0000886982-24-000025.md) | not reported | [11.58](/filings/0000886982-25-000009.md) | [8.62](/filings/0000886982-25-000022.md) | [8.40](/filings/0000886982-25-001411.md) | not reported | [14.12](/filings/0000886982-26-000118.md) | [10.91](/filings/0000886982-26-000297.md) | [12.25](/filings/0000886982-25-001411.md) | not reported | [17.55](/filings/0000886982-26-000118.md) | [20.98](/filings/0000886982-26-000297.md) |
| Basic EPS | $ per share | [5.52](/filings/0000886982-24-000025.md) | not reported | [11.67](/filings/0000886982-25-000009.md) | [8.73](/filings/0000886982-25-000022.md) | [8.52](/filings/0000886982-25-001411.md) | not reported | [14.25](/filings/0000886982-26-000118.md) | [11.03](/filings/0000886982-25-000022.md) | [12.42](/filings/0000886982-25-001411.md) | not reported | [17.74](/filings/0000886982-26-000118.md) | not reported |

- Revenue: us-gaap:RevenuesNetOfInterestExpense
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [240](/filings/0000886982-23-000011.md) | [242](/filings/0000886982-25-000005.md) | [209](/filings/0000886982-24-000016.md) | [206](/filings/0000886982-24-000022.md) | [155](/filings/0000886982-24-000025.md) | [182](/filings/0000886982-26-000091.md) | [167](/filings/0000886982-25-000009.md) | [153](/filings/0000886982-25-000022.md) | [170](/filings/0000886982-25-001411.md) | [164](/filings/0000886982-26-000297.md) | [180](/filings/0000886982-26-000118.md) | [187](/filings/0000886982-26-000297.md) |
| Total assets | $bn | [1,577](/filings/0000886982-23-000011.md) | [1,642](/filings/0000886982-25-000005.md) | [1,698](/filings/0000886982-24-000022.md) | [1,653](/filings/0000886982-24-000025.md) | [1,728](/filings/0000886982-24-000025.md) | [1,676](/filings/0000886982-26-000091.md) | [1,766](/filings/0000886982-25-000022.md) | [1,785](/filings/0000886982-25-001411.md) | [1,808](/filings/0000886982-25-001411.md) | [1,809](/filings/0000886982-26-000297.md) | [2,060](/filings/0000886982-26-000297.md) | [2,128](/filings/0000886982-26-000297.md) |
| Total liabilities | $bn | [1,460](/filings/0000886982-23-000011.md) | [1,525](/filings/0000886982-25-000005.md) | [1,580](/filings/0000886982-24-000022.md) | [1,534](/filings/0000886982-24-000025.md) | [1,607](/filings/0000886982-24-000025.md) | [1,554](/filings/0000886982-26-000091.md) | [1,642](/filings/0000886982-25-000022.md) | [1,661](/filings/0000886982-25-001411.md) | [1,684](/filings/0000886982-25-001411.md) | [1,684](/filings/0000886982-26-000297.md) | [1,937](/filings/0000886982-26-000297.md) | [2,005](/filings/0000886982-26-000297.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | [1.5](/filings/0000886982-23-000011.md) | [75.9](/filings/0000886982-25-000005.md) | [78.6](/filings/0000886982-24-000016.md) | [76.8](/filings/0000886982-24-000022.md) | [75.4](/filings/0000886982-24-000025.md) | [69.7](/filings/0000886982-25-001411.md) | [71.0](/filings/0000886982-25-000009.md) | [69.0](/filings/0000886982-25-000022.md) | [72.4](/filings/0000886982-25-001411.md) | not reported | not reported | not reported |
| Shareholders' equity | $bn | [117](/filings/0000886982-24-000025.md) | [117](/filings/0000886982-26-000091.md) | [119](/filings/0000886982-25-000009.md) | [119](/filings/0000886982-25-000022.md) | [121](/filings/0000886982-25-001411.md) | [122](/filings/0000886982-26-000091.md) | [124](/filings/0000886982-26-000118.md) | [124](/filings/0000886982-26-000297.md) | [124](/filings/0000886982-25-001411.md) | [125](/filings/0000886982-26-000297.md) | [123](/filings/0000886982-26-000118.md) | [123](/filings/0000886982-26-000297.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Short-term borrowings: us-gaap:CommercialPaper, us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $bn | [(25.5) d](/filings/0000886982-24-000025.md) | [(28.4) d](/filings/0000886982-26-000091.md) | [(28.0)](/filings/0000886982-25-000009.md) | [6.1 d](/filings/0000886982-25-000022.md) | [(38.1) d](/filings/0000886982-25-001411.md) | [46.8 d](/filings/0000886982-26-000091.md) | [(37.2)](/filings/0000886982-26-000118.md) | [5.7 d](/filings/0000886982-26-000297.md) | [2.7 d](/filings/0000886982-25-001411.md) | [(16.3) d](/filings/0000886982-26-000091.md) | [(31.9)](/filings/0000886982-26-000118.md) | [6.1 d](/filings/0000886982-26-000297.md) |
| Capital expenditure | $bn | [0.5 d](/filings/0000886982-24-000025.md) | [0.5 d](/filings/0000886982-26-000091.md) | [0.5](/filings/0000886982-25-000009.md) | [0.5 d](/filings/0000886982-25-000022.md) | [0.5 d](/filings/0000886982-25-001411.md) | [0.6 d](/filings/0000886982-26-000091.md) | [0.5](/filings/0000886982-26-000118.md) | [0.5 d](/filings/0000886982-26-000297.md) | [0.6 d](/filings/0000886982-25-001411.md) | [0.5 d](/filings/0000886982-26-000091.md) | [0.6](/filings/0000886982-26-000118.md) | [0.5 d](/filings/0000886982-26-000297.md) |
| Dividends paid | $bn | [1.1 d](/filings/0000886982-24-000025.md) | [1.1 d](/filings/0000886982-26-000091.md) | [1.1](/filings/0000886982-25-000009.md) | [1.1 d](/filings/0000886982-25-000022.md) | [1.2 d](/filings/0000886982-25-001411.md) | [1.2 d](/filings/0000886982-26-000091.md) | [1.1](/filings/0000886982-26-000118.md) | [1.2 d](/filings/0000886982-26-000297.md) | [1.5 d](/filings/0000886982-25-001411.md) | [1.5 d](/filings/0000886982-26-000091.md) | [1.6](/filings/0000886982-26-000118.md) | [1.6 d](/filings/0000886982-26-000297.md) |
| Share repurchases | $bn | [1.5 d](/filings/0000886982-24-000025.md) | [1.0 d](/filings/0000886982-26-000091.md) | [1.5](/filings/0000886982-25-000009.md) | [3.5 d](/filings/0000886982-25-000022.md) | [1.0 d](/filings/0000886982-25-001411.md) | [2.0 d](/filings/0000886982-26-000091.md) | [4.4](/filings/0000886982-26-000118.md) | [3.0 d](/filings/0000886982-26-000297.md) | [2.0 d](/filings/0000886982-25-001411.md) | [3.0 d](/filings/0000886982-26-000091.md) | [5.0](/filings/0000886982-26-000118.md) | [4.0 d](/filings/0000886982-26-000297.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [359](/filings/0000886982-23-000011.md) | [351](/filings/0000886982-24-000016.md) | [347](/filings/0000886982-24-000022.md) | [344](/filings/0000886982-24-000025.md) | [340](/filings/0000886982-25-000009.md) | [336](/filings/0000886982-25-000022.md) | [331](/filings/0000886982-25-001411.md) | [325](/filings/0000886982-26-000118.md) | [318](/filings/0000886982-26-000297.md) | [315](/filings/0000886982-25-001411.md) | [308](/filings/0000886982-26-000118.md) | [305](/filings/0000886982-26-000297.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 291,171,408 at 2026-07-17, from the cover of the [10-Q filed 2026-08-03](/filings/0000886982-26-000297.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:27 ET. No prices; not investment advice.